Prime Minister of India Narendra Modi is applauded for having given himself the Covid-19 vaccine after giving millions of doses of Coronavirus vaccine free of cost to countries around the world under the Vaccine Friendship Campaign. Prime Minister Mia Amore Motley of the Caribbean country of Barbados has praised PM Modi’s generosity. He himself tweeted and wished Prime Minister Modi good health.
PM Motley wrote, ‘Before PM Modi himself got the Coronavirus vaccine, it made it possible for 40 thousand people of Barbados and millions of people in the world to get the Covid-19 vaccine through Vaccine Friendship. This is a real demonstration of his generosity. Thank you very much and I wish you good health. ‘ Earlier on Monday, Prime Minister Narendra Modi had administered the first dose of Covid-19 vaccine at AIIMS in the capital Delhi.
Appealed to contribute to freeing India of Covid-19
Apart from getting the vaccine, PM Modi also appealed to all people to contribute to making India Covid-19 free. The Prime Minister tweeted, “I took the first dose of the Covid-19 vaccine at AIIMS. The speed our doctors and scientists worked to strengthen the global fight against Covid-19 is remarkable.” The PM requested people to cooperate with the vaccine to free India from the Kovid epidemic. He said, “I urge all those who are eligible for this vaccine. Come, let us all make India Covid-19 free.”
A covid vaccine made by Bharat Biotech has been given to PM Modi. This vaccine was approved for emergency use last month with Covishield created by the Serum Institute of India. Modi has not only overcome the doubts related to the vaccine by applying Covaxin, he has done many hunting with one stone. Coronavirus vaccination campaign started in India on 16 January 2021. Prior to that, Covishield and Covaxin were approved on 3 January.
There is no dearth of questions about Covaxin
Covishield has been developed by researchers from Oxford University and AstraZeneca, while Covaxin has been developed by the Indian Council of Medical Research (ICMR) and Bharat Biotech. Covishield received approval after completion of Phase 3 trial while Covaxin was then undergoing Phase 3 trial. In such a situation, there was no dearth of questions about Covaxin. Covaxin was repeatedly put in the dock on behalf of opposition members.